We recently identified a new regulatory network consisting of the hypoxia-inducible transcription factor HIF-1A and the p53-inducible miR-34a that determines whether a tumor cell undergoes EMT (epithelial-mesenchymal transition) or MET (mesenchymal-epithelial transition) under hypoxic conditions. Here, HIF1A is linked to neoplasm.